China Cord Blood Corp. (NYSE:CO)
CAPS Rating:
The company operates as a cord blood bank in China, providing laboratory testing, cord blood collection, stem cell storage services, and hematopoietic stem cell processing.
The company operates as a cord blood bank in China, providing laboratory testing, cord blood collection, stem cell storage services, and hematopoietic stem cell processing.
Recs
Cash flow has gone from negative to positive this year.
Insider ownership is almost 63%. That's good evidence to me that cash flow won't be going negative again any time soon.